journal article·2020-05-27Open access

Synthetic alternatives to Matrigel

Elizabeth A. Aisenbrey, William L. Murphy

Nature Reviews Materials· Volume 5· Issue 7

Abstract

Matrigel, a basement-membrane matrix extracted from Engelbreth-Holm-Swarm mouse sarcomas, has been used for more than four decades for a myriad of cell culture applications. However, Matrigel is limited in its applicability to cellular biology, therapeutic cell manufacturing and drug discovery owing to its complex, ill-defined and variable composition. Variations in the mechanical and biochemical properties within a single batch of Matrigel - and between batches - have led to uncertainty in cell culture experiments and a lack of reproducibility. Moreover, Matrigel is not conducive to physical or biochemical manipulation, making it difficult to fine-tune the matrix to promote intended cell behaviours and achieve specific biological outcomes. Recent advances in synthetic scaffolds have led to the development of xenogenic-free, chemically defined, highly tunable and reproducible alternatives. In this Review, we assess the applications of Matrigel in cell culture, regenerative medicine and organoid assembly, detailing the limitations of Matrigel and highlighting synthetic scaffold alternatives that have shown equivalent or superior results. Additionally, we discuss the hurdles that are limiting a full transition from Matrigel to synthetic scaffolds and provide a brief perspective on the future directions of synthetic scaffolds for cell culture applications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Tissue Engineering and Regenerative Medicine · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Orkin, R. W. et al. A murine tumor producing a matrix of basement membrane. J. Exp. Med. 145, 204–220 (1977).10.1084/jem.145.1.204 ↗
2. LeBleu, V. S., Macdonald, B. & Kalluri, R. Structure and function of basement membranes. Exp. Biol. Med. 232, 1121–1129 (2007).10.3181/0703-MR-72 ↗
3. Kubota, Y., Kleinman, H. K., Martin, G. R. & Lawley, T. J. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell Biol. 107, 1589–1598 (1988).10.1083/jcb.107.4.1589 ↗
4. Kleinman, H. K. et al. Basement membrane complexes with biological activity. Biochemistry 25, 312–318 (1986). This paper investigates the protein composition and biological activity of the basement-membrane extract from EHS mouse chondrosarcomas; this extract was later developed and commercialized as Matrigel.10.1021/bi00350a005 ↗
5. Kleinman, H. K. & Martin, G. R. Matrigel: basement membrane matrix with biological activity. Semin. Cancer Biol. 15, 378–386 (2005).10.1016/j.semcancer.2005.05.004 ↗
6. Corning Incorporated Life Sciences. Corning Matrigel matrix. Frequently asked questions (Corning, 2019).
7. Hughes, C. S., Postovit, L. M. & Lajoie, G. A. Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10, 1886–1890 (2010). A full proteomic analysis of Matrigel and GFR Matrigel, reporting their complex, ill-defined and variable composition.10.1002/pmic.200900758 ↗
8. Timpl, R. et al. Laminin — a glycoprotein from basement membranes. J. Biol. Chem. 254, 9933–9937 (1979).10.1016/S0021-9258(19)83607-4 ↗
9. Terranova, V. P., Aumailley, M., Sultan, L. H., Martin, G. R. & Kleinman, H. K. Regulation of cell attachment and cell number by fibronectin and laminin. J. Cell. Physiol. 127, 473–479 (1986).10.1002/jcp.1041270318 ↗
10. Miyazaki, T. et al. Recombinant human laminin isoforms can support the undifferentiated growth of human embryonic stem cells. Biochem. Biophys. Res. Commun. 375, 27–32 (2008).10.1016/j.bbrc.2008.07.111 ↗
11. Ponce, M. L. et al. Identification of endothelial cell binding sites on the laminin γ1 chain. Circ. Res. 84, 688–694 (1999).10.1161/01.RES.84.6.688 ↗
12. Wang, K., Ji, L. & Hua, Z. Functional peptides from laminin-1 improve the cell adhesion capacity of recombinant mussel adhesive protein. Protein Pept. Lett. 24, 348–352 (2017).10.2174/0929866524666170123142225 ↗
13. Heaton, M. B. & Swanson, D. J. The influence of laminin on the initial differentiation of cultured neural tube neurons. J. Neurosci. Res. 19, 212–218 (1988).10.1002/jnr.490190206 ↗
14. Farrukh, A. et al. Bifunctional hydrogels containing the laminin motif IKVAV promote neurogenesis. Stem Cell Rep. 9, 1432–1440 (2017).10.1016/j.stemcr.2017.09.002 ↗
15. Ali, S., Saik, J. E., Gould, D. J., Dickinson, M. E. & West, J. L. Immobilization of cell-adhesive laminin peptides in degradable PEGDA hydrogels influences endothelial cell tubulogenesis. BioResearch Open Access 2, 241–249 (2013).10.1089/biores.2013.0021 ↗
16. Engbring, J. A. & Kleinman, H. K. The basement membrane matrix in malignancy. J. Pathol. 200, 465–470 (2003).10.1002/path.1396 ↗
17. Kikkawa, Y. et al. Laminin-111-derived peptides and cancer. Cell Adh. Migr. 7, 150–159 (2013).10.4161/cam.22827 ↗
18. Vukicevic, S. et al. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp. Cell Res. 202, 1–8 (1992). This study identifies multiple active growth factors in Matrigel and suggests caution when interpreting cellular activity when cultured on Matrigel.10.1016/0014-4827(92)90397-Q ↗
19. Talbot, N. C. & Caperna, T. J. Proteome array identification of bioactive soluble proteins/peptides in Matrigel: relevance to stem cell responses. Cytotechnology 67, 873–883 (2015).10.1007/s10616-014-9727-y ↗
20. Gillette, K. M., Forbes, K. & Sehgal, I. Detection of matrix metalloproteinases (MMP), tissue inhibitor of metalloproteinase-2, urokinase and plasminogen activator inhibitor-1 within Matrigel and growth factor-reduced Matrigel basement membrane. Tumori 89, 421–425 (2003).10.1177/030089160308900415 ↗
21. Xu, C. et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19, 971–974 (2001).10.1038/nbt1001-971 ↗
22. Qian, L. & Saltzman, W. M. Improving the expansion and neuronal differentiation of mesenchymal stem cells through culture surface modification. Biomaterials 25, 1331–1337 (2004).10.1016/j.biomaterials.2003.08.013 ↗
23. Lee, S.-W. et al. Optimization of Matrigel-based culture for expansion of neural stem cells. Anim. Cell Syst. 19, 175–180 (2015).10.1080/19768354.2015.1035750 ↗
24. Laflamme, M. A. et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25, 1015–1024 (2007).10.1038/nbt1327 ↗
25. Ponce, M. L. Tube formation: an in vitro Matrigel angiogenesis assay. Methods Mol. Biol. 467, 183–188 (2009).10.1007/978-1-59745-241-0_10 ↗
26. Ponce, M. L. In vitro Matrigel angiogenesis assays. Methods Mol. Med. 46, 205–209 (2001).
27. Mondrinos, M. J. et al. Engineering three-dimensional pulmonary tissue constructs. Tissue Eng. 12, 717–728 (2006).10.1089/ten.2006.12.717 ↗
28. Li, Z. & Guan, J. Hydrogels for cardiac tissue engineering. Polymers 3, 740–761 (2011).10.3390/polym3020740 ↗
29. Lancaster, M. A. & Knoblich, J. A. Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345, 1247125 (2014).10.1126/science.1247125 ↗
30. Lancaster, M. A. et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373–379 (2013).10.1038/nature12517 ↗
31. Benton, G., Kleinman, H. K., George, J. & Arnaoutova, I. Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells. Int. J. Cancer 128, 1751–1757 (2011).10.1002/ijc.25781 ↗
32. Cruz-Acuña, R. & García, A. J. Synthetic hydrogels mimicking basement membrane matrices to promote cell-matrix interactions. Matrix Biol. 57–58, 324–333 (2017).10.1016/j.matbio.2016.06.002 ↗
33. Polykandriotis, E., Arkudas, A., Horch, R. E., Kneser, U. & Mitchell, G. To Matrigel or not to Matrigel. Am. J. Pathol. 172, 1441–1442 (2008).10.2353/ajpath.2008.071215 ↗
34. Kohen, N. T., Little, L. E. & Healy, K. E. Characterization of Matrigel interfaces during defined human embryonic stem cell culture. Biointerphases 4, 69–79 (2009).10.1116/1.3274061 ↗
35. Soofi, S. S., Last, J. A., Liliensiek, S. J., Nealey, P. F. & Murphy, C. J. The elastic modulus of Matrigel as determined by atomic force microscopy. J. Struct. Biol. 167, 216–219 (2009).10.1016/j.jsb.2009.05.005 ↗
36. Dirami, G. et al. Identification of transferrin and inhibin-like proteins in Matrigel. In Vitro Cell. Dev. Biol. Anim. 31, 409–411 (1995).10.1007/BF02634247 ↗
37. Hansen, K. C. et al. An in-solution ultrasonication-assisted digestion method for improved extracellular matrix proteome coverage. Mol. Cell. Proteom. 8, 1648–1657 (2009).10.1074/mcp.M900039-MCP200 ↗
38. Zaman, M. H. et al. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc. Natl Acad. Sci. USA 103, 10889–10894 (2006).10.1073/pnas.0604460103 ↗
39. Semler, E. J., Ranucci, C. S. & Moghe, P. V. Mechanochemical manipulation of hepatocyte aggregation can selectively induce or repress liver-specific function. Biotechnol. Bioeng. 69, 359–369 (2000).10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q ↗
40. Kane, K. I. W. et al. Determination of the rheological properties of Matrigel for optimum seeding conditions in microfluidic cell cultures. AIP Adv. 8, 125332 (2018).10.1063/1.5067382 ↗
41. Alcaraz, J. et al. Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epithelia. EMBO J. 27, 2829–2838 (2008).10.1038/emboj.2008.206 ↗
42. Reed, J., Walczak, W. J., Petzold, O. N. & Gimzewski, J. K. In situ mechanical interferometry of Matrigel films. Langmuir 25, 36–39 (2009).10.1021/la8033098 ↗
43. Peterson, N. C. From bench to cageside: risk assessment for rodent pathogen contamination of cells and biologics. ILAR J. 49, 310–315 (2008).10.1093/ilar.49.3.310 ↗
44. Liu, H. et al. Removal of lactate dehydrogenase-elevating virus from human-in-mouse breast tumor xenografts by cell-sorting. J. Virol. Methods 173, 266–270 (2011).10.1016/j.jviromet.2011.02.015 ↗
45. Ammann, C. G., Messer, R. J., Peterson, K. E. & Hasenkrug, K. J. Lactate dehydrogenase-elevating virus induces systemic lymphocyte activation via TLR7-dependent IFNα responses by plasmacytoid dendritic cells. PLoS One 4, e6105 (2009).10.1371/journal.pone.0006105 ↗
46. Riley, V. et al. The LDH virus: an interfering biological contaminant. Science 200, 124–126 (1978).10.1126/science.263259 ↗
47. Caliari, S. R. & Burdick, J. A. A practical guide to hydrogels for cell culture. Nat. Methods 13, 405–414 (2016).10.1038/nmeth.3839 ↗
48. Li, X., Sun, Q., Li, Q., Kawazoe, N. & Chen, G. Functional hydrogels with tunable structures and properties for tissue engineering applications. Front. Chem. 6, 499 (2018).10.3389/fchem.2018.00499 ↗
49. Fischer, R. S., Myers, K. A., Gardel, M. L. & Waterman, C. M. Stiffness-controlled three-dimensional extracellular matrices for high-resolution imaging of cell behavior. Nat. Protoc. 7, 2056–2066 (2012).10.1038/nprot.2012.127 ↗
50. Tse, J. R. & Engler, A. J. Preparation of hydrogel substrates with tunable mechanical properties. Curr. Protoc. Cell Biol. 47, 10.16.1–10.16.16 (2010).
51. Pelham, R. J. Jr. & Wang, Y.-l. Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc. Natl Acad. Sci. USA 94, 13661–13665 (1997).10.1073/pnas.94.25.13661 ↗
52. Zustiak, S. P. & Leach, J. B. Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds with tunable degradation and mechanical properties. Biomacromolecules 11, 1348–1357 (2010).10.1021/bm100137q ↗
53. Krsko, P. & Libera, M. Biointeractive hydrogels. Mater. Today 8, 36–44 (2005).10.1016/S1369-7021(05)71223-2 ↗
54. Zhu, J. Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials 31, 4639–4656 (2010).10.1016/j.biomaterials.2010.02.044 ↗
55. Lin, C.-C. & Anseth, K. S. PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm. Res. 26, 631–643 (2009).10.1007/s11095-008-9801-2 ↗
56. Tibbitt, M. W. & Anseth, K. S. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol. Bioeng. 103, 655–663 (2009).10.1002/bit.22361 ↗
57. Fairbanks, B. D. et al. A versatile synthetic extracellular matrix mimic via thiol-norbornene photopolymerization. Adv. Mater. 21, 5005–5010 (2009).10.1002/adma.200901808 ↗
58. Bryant, S. & Anseth, K. in Scaffolding in Tissue Engineering (eds Ma, P. X. & Elisseeff, J.) 71–90 (CRC, 2005).10.1201/9781420027563.ch6 ↗
59. Nguyen, K. T. & West, J. L. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 23, 4307–4314 (2002).10.1016/S0142-9612(02)00175-8 ↗
60. Nair, D. P. et al. The thiol-Michael addition click reaction: a powerful and widely used tool in materials chemistry. Chem. Mater. 26, 724–744 (2014).10.1021/cm402180t ↗
61. Schense, J. C. & Hubbell, J. A. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjug. Chem. 10, 75–81 (1999).10.1021/bc9800769 ↗
62. Ehrbar, M. et al. Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions. Biomacromolecules 8, 3000–3007 (2007).10.1021/bm070228f ↗
63. Bryant, S. J., Chowdhury, T. T., Lee, D. A., Bader, D. L. & Anseth, K. S. Crosslinking density influences chondrocyte metabolism in dynamically loaded photocrosslinked poly(ethylene glycol) hydrogels. Ann. Biomed. Eng. 32, 407–417 (2004).10.1023/B:ABME.0000017535.00602.ca ↗
64. Roberts, J. J. & Bryant, S. J. Comparison of photopolymerizable thiol-ene PEG and acrylate-based PEG hydrogels for cartilage development. Biomaterials 34, 9969–9979 (2013).10.1016/j.biomaterials.2013.09.020 ↗
65. Burdick, J. A. & Anseth, K. S. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 23, 4315–4323 (2002).10.1016/S0142-9612(02)00176-X ↗
66. Kharkar, P. M., Rehmann, M. S., Skeens, K. M., Maverakis, E. & Kloxin, A. M. Thiol–ene click hydrogels for therapeutic delivery. ACS Biomater. Sci. Eng. 2, 165–179 (2016).10.1021/acsbiomaterials.5b00420 ↗
67. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998).10.1126/science.282.5391.1145 ↗
68. Avior, Y., Sagi, I. & Benvenisty, N. Pluripotent stem cells in disease modelling and drug discovery. Nat. Rev. Mol. Cell Biol. 17, 170–182 (2016).10.1038/nrm.2015.27 ↗
69. Singh, V. K., Kalsan, M., Kumar, N., Saini, A. & Chandra, R. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front. Cell Dev. Biol. 3, 2 (2015).10.3389/fcell.2015.00002 ↗
70. Shi, Y., Inoue, H., Wu, J. C. & Yamanaka, S. Induced pluripotent stem cell technology: a decade of progress. Nat. Rev. Drug. Discov. 16, 115–130 (2017).10.1038/nrd.2016.245 ↗
71. Ortiz-Vitali, J. L. & Darabi, R. iPSCs as a platform for disease modeling, drug screening, and personalized therapy in muscular dystrophies. Cells 8, 20 (2019).10.3390/cells8010020 ↗
72. Hovatta, O. Derivation of human embryonic stem cell lines, towards clinical quality. Reprod. Fertil. Dev. 18, 823–828 (2006).10.1071/RD06075 ↗
73. Qian, X., Villa-Diaz, L. G., Kumar, R., Lahann, J. & Krebsbach, P. H. Enhancement of the propagation of human embryonic stem cells by modifications in the gel architecture of PMEDSAH polymer coatings. Biomaterials 35, 9581–9590 (2014).10.1016/j.biomaterials.2014.08.015 ↗
74. Nandivada, H. et al. Fabrication of synthetic polymer coatings and their use in feeder-free culture of human embryonic stem cells. Nat. Protoc. 6, 1037–1043 (2011).10.1038/nprot.2011.342 ↗
75. Villa-Diaz, L. G. et al. Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat. Biotechnol. 28, 581–583 (2010). Along with reference 74, this was one of the first studies to develop a fully synthetic, chemically defined scaffold for long-term hESC culture and to directly compare the performance with that of Matrigel.10.1038/nbt.1631 ↗
76. Brafman, D. A. et al. Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials 31, 9135–9144 (2010).10.1016/j.biomaterials.2010.08.007 ↗
77. Meng, Y. et al. Characterization of integrin engagement during defined human embryonic stem cell culture. FASEB J. 24, 1056–1065 (2009).10.1096/fj.08-126821 ↗
78. Rowland, T. J. et al. Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cell Dev. 19, 1231–1240 (2010).10.1089/scd.2009.0328 ↗
79. Mondal, G., Barui, S. & Chaudhuri, A. The relationship between the cyclic-RGDfK ligand and αvβ3 integrin receptor. Biomaterials 34, 6249–6260 (2013).10.1016/j.biomaterials.2013.04.065 ↗
80. Lambshead, J. W. et al. Long-term maintenance of human pluripotent stem cells on cRGDfK-presenting synthetic surfaces. Sci. Rep. 8, 701 (2018).10.1038/s41598-018-19209-0 ↗
81. Nguyen, E. H. et al. Versatile synthetic alternatives to Matrigel for vascular toxicity screening and stem cell expansion. Nat. Biomed. Eng. 1, 0096 (2017). This study uses a high-throughput screening method of synthetic scaffolds to determine a synthetic alternative to Matrigel, finding that matrix-induced effects caused by the biological function of Matrigel can affect toxicity screenings.10.1038/s41551-017-0096 ↗
82. Hayman, E. G., Pierschbacher, M. D., Suzuki, S. & Ruoslahti, E. Vitronectin — a major cell attachment-promoting protein in fetal bovine serum. Exp. Cell Res. 160, 245–258 (1985).10.1016/0014-4827(85)90173-9 ↗
83. Melkoumian, Z. et al. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat. Biotechnol. 28, 606–610 (2010). An early report on tethering synthetic peptides to synthetic scaffolds that provides a direct comparison with Matrigel.10.1038/nbt.1629 ↗
84. Deng, Y. et al. Long-term self-renewal of human pluripotent stem cells on peptide-decorated poly(OEGMA-co-HEMA) brushes under fully defined conditions. Acta Biomater. 9, 8840–8850 (2013).10.1016/j.actbio.2013.07.017 ↗
85. Higuchi, A. et al. Long-term xeno-free culture of human pluripotent stem cells on hydrogels with optimal elasticity. Sci. Rep. 5, 18136 (2015).
86. Jin, S., Yao, H., Weber, J. L., Melkoumian, Z. K. & Ye, K. A synthetic, xeno-free peptide surface for expansion and directed differentiation of human induced pluripotent stem cells. PLoS One 7, e50880 (2012).
87. Yasuda, S. et al. Chemically defined and growth-factor-free culture system for the expansion and derivation of human pluripotent stem cells. Nat. Biomed. Eng. 2, 173–182 (2018).10.1038/s41551-018-0200-7 ↗
88. Farach-Carson, M. C. & Carson, D. D. Perlecan — a multifunctional extracellular proteoglycan scaffold. Glycobiology 17, 897–905 (2007).10.1093/glycob/cwm043 ↗
89. Furue, M. K. et al. Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proc. Natl Acad. Sci. USA 105, 13409–13414 (2008).10.1073/pnas.0806136105 ↗
90. Spivak-Kroizman, T. et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79, 1015–1024 (1994).10.1016/0092-8674(94)90032-9 ↗
91. Vlodavsky, I., Miao, H. Q., Medalion, B., Danagher, P. & Ron, D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev. 15, 177–186 (1996).10.1007/BF00437470 ↗
92. Chang, C.-W. et al. Engineering cell–material interfaces for long-term expansion of human pluripotent stem cells. Biomaterials 34, 912–921 (2013).10.1016/j.biomaterials.2012.10.020 ↗
93. Klim, J. R., Li, L., Wrighton, P. J., Piekarczyk, M. S. & Kiessling, L. L. A defined glycosaminoglycan-binding substratum for human pluripotent stem cells. Nat. Methods 7, 989–994 (2010).10.1038/nmeth.1532 ↗
94. Musah, S. et al. Glycosaminoglycan-binding hydrogels enable mechanical control of human pluripotent stem cell self-renewal. ACS Nano 6, 10168–10177 (2012).10.1021/nn3039148 ↗
95. Gerecht, S. et al. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc. Natl Acad. Sci. USA 104, 11298–11303 (2007).10.1073/pnas.0703723104 ↗
96. Lei, Y. & Schaffer, D. V. A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc. Natl Acad. Sci. USA 110, E5039–E5048 (2013).
97. Ovadia, E. M., Colby, D. W. & Kloxin, A. M. Designing well-defined photopolymerized synthetic matrices for three-dimensional culture and differentiation of induced pluripotent stem cells. Biomater. Sci. 6, 1358–1370 (2018).10.1039/C8BM00099A ↗
98. Murphy, W. L., McDevitt, T. C. & Engler, A. J. Materials as stem cell regulators. Nat. Mater. 13, 547–557 (2014).10.1038/nmat3937 ↗
99. Folkman, J. & Moscona, A. Role of cell shape in growth control. Nature 273, 345–349 (1978).10.1038/273345a0 ↗
100. Caiazzo, M. et al. Defined three-dimensional microenvironments boost induction of pluripotency. Nat. Mater. 15, 344–352 (2016).10.1038/nmat4536 ↗